Discontinuation criteria
psychiatric
ADVERSE EVENTS, ADVERSE REACTIONS
The discontinuation criteria will be as follows: (1) serious adverse events or adverse reactions that make it difficult to continue the intervention; (2) worsening of physical or psychiatric symptoms, or emergence of new symptoms that make it impossible to continue the intervention; (3) patient desire to discontinue the intervention; (4) interval of 1 month or more between sessions attended; (5) regular use of psychotropic drugs at the discretion of the attending physician during the implementation of the program or while waiting; (6) meeting the exclusion criteria while waiting; and (7) any other reason for which the attending physician deems it necessary to discontinue the intervention.If this study will be discontinued, the date on which the decision for discontinuation was made and the reason for discontinuation will be noted on the case registration form. The data center will be informed of the discontinuation.If serious adverse events or adverse reactions, such as worsening of psychiatric or physical symptoms, occurs and it is deemed difficult to continue the intervention, the therapist will promptly inform the research director at each research institution and discontinue this study. The research director at each research institution contacted will promptly inform the research representative and data center of the decision for discontinuation.